The sarcoma program at Presbyterian/St. Luke’s Medical Center (P/SL), in partnership with Sarah Cannon Cancer Institute, is committed to providing the best sarcoma care in Denver. Founded as part of the Institute for Limb Preservation (ILP) by Dr. Ross Wilkins and Dr. Tom Arganese in 1986, the sarcoma program at P/SL is recognized for its national expertise in the management of pediatric and adult extremity tumors. Our multidisciplinary team provides expert evaluation and treatment for patients with bone or soft tissue tumors.
What is sarcoma?
Sarcoma is the name for cancerous tumors in the body’s connective tissue (bones, muscle, cartilage, nerves, fat, blood vessels and deep skin tissue) and are separated into two main groups – bone sarcomas and soft tissue sarcomas. Although rare, about 15,000 cases of sarcoma are diagnosed in the US each year.
Metastatic bone cancer
Metastatic bone cancer happens when cancer cells from a primary tumor (commonly prostate, breast and lung cancer) spread to the bone. In addition to primary bone and soft tissue tumors, our physicians specialize in the management of patients with metastatic bone tumors. We can work with the referring oncologist to best approach pathologic fracture processes and plan surgical intervention.
Innovative surgical treatment for sarcoma
Our approach to patient care focuses on “life over limb,” but with successful management of tumors using the appropriate chemotherapy protocols, we offer many limb-sparing surgical options. Some of these innovative techniques have been pioneered by physicians on our team.
- Allograft Procedures
- Clinical Research
- Custom Implant Designs
- Foam Metal Technologies
- Growing Prosthesis for Children
- Innovative Amputation Techniques
- Soft Tissue Reconstruction Options
From understanding your diagnosis and coordinating appointments, to learning about clinical trials and transitioning into survivorship, our cancer nurse navigator is there for you through every step of the way.